Exxonmobil Investment Management Raised By $6.02 Million Its Intercontinental Exchange (ICE) Position; Ra Capital Management Has Upped Its Achillion Pharmaceuticals (ACHN) Position

July 10, 2017 - By Dolores Ford

Exxonmobil Investment Management Inc increased Intercontinental Exchange Inc (ICE) stake by 353.27% reported in 2016Q4 SEC filing. Exxonmobil Investment Management Inc acquired 107,460 shares as Intercontinental Exchange Inc (ICE)’s stock rose 1.58%. The Exxonmobil Investment Management Inc holds 137,879 shares with $7.78M value, up from 30,419 last quarter. Intercontinental Exchange Inc now has $39.00 billion valuation. The stock decreased 0.08% or $0.05 on July 7, reaching $65.92. About shares traded. Intercontinental Exchange Inc (NYSE:ICE) has risen 13.80% since July 10, 2016 and is uptrending. It has underperformed by 2.90% the S&P500.

Ra Capital Management Llc increased Achillion Pharmaceuticals Inc (ACHN) stake by 13.3% reported in 2016Q4 SEC filing. Ra Capital Management Llc acquired 1.60M shares as Achillion Pharmaceuticals Inc (ACHN)’s stock 0.00%. The Ra Capital Management Llc holds 13.63M shares with $56.31M value, up from 12.03 million last quarter. Achillion Pharmaceuticals Inc now has $641.46 million valuation. The stock decreased 1.85% or $0.09 on July 7, reaching $4.78. About shares traded. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) has declined 47.61% since July 10, 2016 and is downtrending. It has underperformed by 64.31% the S&P500.

Investors sentiment increased to 11.77 in 2016 Q4. Its up 10.76, from 1.01 in 2016Q3. It increased, as 32 investors sold ICE shares while 16 reduced holdings. 77 funds opened positions while 488 raised stakes. 1.03 billion shares or 903.33% more from 102.32 million shares in 2016Q3 were reported. Oakwood Capital Management Limited Liability Corporation Ca has 85,985 shares. Suntrust Banks reported 64,452 shares or 0.02% of all its holdings. Creative Planning reported 7,694 shares or 0% of all its holdings. Raab And Moskowitz Asset Management Ltd Company stated it has 0.22% of its portfolio in Intercontinental Exchange Inc (NYSE:ICE). 1.72 million are owned by Public Employees Retirement Association Of Colorado. Yorkville Cap Mgmt Ltd holds 0.53% or 9,500 shares. Citizens And Northern Corporation stated it has 1.54% of its portfolio in Intercontinental Exchange Inc (NYSE:ICE). Sumitomo Life accumulated 0.16% or 19,587 shares. Marietta Partners Ltd has 0.27% invested in Intercontinental Exchange Inc (NYSE:ICE). Exxonmobil Management Tx holds 0.17% or 137,879 shares in its portfolio. Ubs Oconnor Ltd accumulated 0% or 66,660 shares. First Commonwealth Fincl Pa has invested 0.67% of its portfolio in Intercontinental Exchange Inc (NYSE:ICE). Arrow Financial holds 36,825 shares. State Of Alaska Department Of Revenue accumulated 0.3% or 58,035 shares. Financial Bank Of Montreal Can holds 0% or 30,629 shares in its portfolio.

Exxonmobil Investment Management Inc decreased O Reilly Automotive Inc New Co (NASDAQ:ORLY) stake by 2,374 shares to 21,865 valued at $6.09M in 2016Q4. It also reduced Dollar Gen Corp New Com (NYSE:DG) stake by 7,354 shares and now owns 58,830 shares. Bristol Myers Squibb Co Com (NYSE:BMY) was reduced too.

Among 13 analysts covering Intercontinental Exchange (NYSE:ICE), 10 have Buy rating, 0 Sell and 3 Hold. Therefore 77% are positive. Intercontinental Exchange had 40 analyst reports since August 6, 2015 according to SRatingsIntel. The stock of Intercontinental Exchange Inc (NYSE:ICE) earned “Buy” rating by Deutsche Bank on Friday, January 8. The firm has “Buy” rating given on Friday, March 24 by Wood. As per Friday, March 31, the company rating was reinitiated by RBC Capital Markets. The firm has “Neutral” rating by JP Morgan given on Wednesday, June 1. Keefe Bruyette & Woods maintained it with “Buy” rating and $65.5000 target in Friday, June 16 report. Jefferies maintained Intercontinental Exchange Inc (NYSE:ICE) on Monday, June 26 with “Buy” rating. The rating was maintained by Deutsche Bank with “Buy” on Thursday, August 6. The rating was maintained by RBC Capital Markets with “Sector Perform” on Tuesday, May 10. The firm has “Buy” rating given on Thursday, May 19 by Buckingham Research. The firm has “Overweight” rating by Barclays Capital given on Friday, September 4.

Among 10 analysts covering Achillion Pharma (NASDAQ:ACHN), 8 have Buy rating, 0 Sell and 2 Hold. Therefore 80% are positive. Achillion Pharma has $16 highest and $4 lowest target. $9.86’s average target is 106.28% above currents $4.78 stock price. Achillion Pharma had 17 analyst reports since August 13, 2015 according to SRatingsIntel. FBR Capital initiated the shares of ACHN in report on Thursday, September 15 with “Outperform” rating. The firm earned “Buy” rating on Thursday, February 2 by Ladenburg Thalmann. The firm has “Sell” rating by Chardan Capital Markets given on Thursday, July 14. The stock of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) earned “Market Perform” rating by Leerink Swann on Friday, January 29. As per Friday, September 23, the company rating was initiated by Wedbush. The rating was upgraded by JMP Securities on Thursday, July 7 to “Market Outperform”. The company was upgraded on Friday, February 26 by Robert W. Baird. The rating was maintained by Maxim Group on Thursday, August 13 with “Buy”. The firm has “Outperform” rating given on Thursday, May 18 by Leerink Swann. The firm has “Sell” rating given on Friday, September 23 by Chardan Capital Markets.

Investors sentiment decreased to 1.09 in 2016 Q4. Its down 0.43, from 1.52 in 2016Q3. It turned negative, as 32 investors sold ACHN shares while 33 reduced holdings. 22 funds opened positions while 49 raised stakes. 97.41 million shares or 7.54% less from 105.36 million shares in 2016Q3 were reported. Axa holds 846,611 shares or 0.02% of its portfolio. Tudor Inv Et Al holds 195,149 shares or 0.02% of its portfolio. 1.52 million are owned by Fmr Limited. Moreover, Da Davidson has 0.01% invested in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN). Tiaa Cref Mgmt has invested 0% in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN). Swiss Retail Bank has invested 0% in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN). Raymond James has invested 0% in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN). Cwm Limited Liability Co invested in 0% or 75 shares. Guggenheim Limited Co invested in 0% or 15,525 shares. Wells Fargo & Communication Mn, a California-based fund reported 192,889 shares. Rhenman Partners Asset Mngmt holds 0.13% or 166,000 shares. Ubs Asset Americas Inc reported 29,198 shares stake. 843,500 are held by South Dakota Council. Tower Rech Llc (Trc) reported 2,291 shares. Jpmorgan Chase & has 448,970 shares.

Ra Capital Management Llc decreased Ardelyx Inc (NASDAQ:ARDX) stake by 1.33 million shares to 1.94M valued at $27.48 million in 2016Q4. It also reduced Strongbridge Biopharma Plc stake by 222,568 shares and now owns 2.28 million shares. Arca Biopharma Inc was reduced too.